Min Jae Kim

Min Jae Kim

Korean Medical Science, Pusan National University School of Korean Medicine, Yangsan, Gyeongnam, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2022 in Advanced Science
Verified
Journal Article
Open access
PDF file
HKHyunha Kim
Hyunha Kim
MKMin Jae Kim
Min Jae Kim
YKYoung Woo Kwon
Young Woo Kwon
SJSangheon Jeon
Sangheon Jeon
SLSeo‐Yeon Lee
Seo‐Yeon Lee
HSHwa-Kyoung Shin
Hwa-Kyoung Shin
Photobiomodulation (PBM) has received attention due to its potential for improving tissue function and enhancing regeneration in stroke. A lightweight, compact, and simple system of miniaturized electronic devices consisting of packaged light‐emitting diodes (LEDs) that incorporates a flexible substrate for in vivo brain PBM in a mouse model is developed. Using this device platform, the preventive and therapeutic effects of PBM affixed to the exposed skull of mice in the photothrombosis and middle cerebral artery occlusion stroke model are evaluated. Among the wavelength range of 630, 850, and 940 nm LED array, the PBM with 630‐nm LED array is proved to be the most effective for reducing the infarction volume and neurological impairment after ischemic stroke. Moreover, the PBM with 630 nm LED array remarkably improves the capability of spatial learning and memory in the chronic poststroke phase, attenuates AIM2 inflammasome activation and inflammasome‐mediated pyroptosis, and modulates microglial polarization in the hippocampus and cortex 7 days following ischemic stroke. Thus, PBM may prevent tissue and functional damage in acute ischemic injury, thereby attenuating the development of cognitive impairment after stroke.

10 February 2025 in Advanced Science
Verified
Journal Article
Open access
MKMin Jae Kim
Min Jae Kim
JYJiman Youn
Jiman Youn
HLHong Ju Lee
Hong Ju Lee
SLSeo-Yeon Lee
Seo-Yeon Lee
TKTae‐Gyu Kim
Tae‐Gyu Kim
HSHwa-Kyoung Shin
Hwa-Kyoung Shin
Ischemic brain injury not only results in significant neurological, motor, and cognitive impairment but also contributes to the accumulation of toxic solutes and proinflammatory cytokines in the infarction region, exacerbating ischemic brain damage. The glymphatic system, which is crucial for brain waste clearance and homeostasis, is impaired by ischemic injury, highlighting the importance of developing therapeutic strategies for poststroke complications. Herein, a novel hybrid electro‐optical stimulation device is proposed that integrates near‐infrared micro‐light‐emitting diode with transparent microneedles, enabling efficient noninvasive stimulation of the cortical area for ischemic stroke treatment. This study investigates whether this hybrid electro‐optical stimulation enhances the glymphatic system function and ameliorates ischemic brain injury in the middle cerebral artery occlusion and reperfusion (MCAO/R) mice model. The results demonstrate that hybrid stimulation improves the neurological, motor, and cognitive functions and reduces brain atrophy following MCAO/R. Moreover, hybrid stimulation restores impaired glymphatic system function by modulation of aquaporin‐4 (AQP4) polarization and alleviates the accumulation of proinflammatory cytokines such as IL‐1β. Notably, AQP4 inhibition partly reverses the improved functional outcomes of hybrid stimulation. The findings suggest that targeting glymphatic drainage using hybrid electro‐optical stimulation is a promising therapeutic approach for treating ischemic brain injury.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MKMin Jae Kim
Min Jae Kim
SLSeo-Yeon Lee
Seo-Yeon Lee
JHJi Young Hwang
Ji Young Hwang
HKHyunha Kim
Hyunha Kim
KiTae HaKiTae Ha
KiTae Ha
HSHwa-Kyoung Shin
Hwa-Kyoung Shin
Aim. Although stroke is among the leading causes of death and long‐term disability, there are few effective treatments for limiting the severity of neurological sequelae. We evaluated the effects of 29 medicinal herbs listed in the Pung chapter of the 17th century Korean medical text Dongui Bogam on stroke symptoms in a mouse model of cerebral ischemia. Methods. Focal cerebral ischemia was induced via photothrombosis. Infarct volume, brain edema, and neurological deficits were evaluated. Immunofluorescence staining for tight junction proteins and aquaporin 4 (AQP4) was performed following ischemic injury. Results. Based on our initial findings, we examined the effects of two prescriptions in which the candidate herbs comprised more than 60% of the total formula: Shuanghe‐tang and Zengsunsiwu‐tang. Pretreatment with Shuanghe‐tang significantly reduced infarct volume, decreased blood‐brain barrier (BBB) breakdown, attenuated edema, and improved neurological and motor functions in a dose‐dependent manner (30, 100, and 300 mg/kg), while no such effects were observed in mice pretreated with Zengsunsiwu‐tang. Immunohistochemical analysis revealed significant increases in ipsilateral occludin and zonula occludens 1 (ZO‐1) expression in Shuanghe‐tang‐pretreated mice, as well as increased AQP4 immunofluorescence. Conclusions. These results indicate that Shuanghe‐tang may protect against brain injury and promote recovery of neurological function following ischemia.

3 December 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MKMin Jae Kim
Min Jae Kim
KPKi Hyun Park
Ki Hyun Park
JLJi Yun Lee
Ji Yun Lee
KiTae HaKiTae Ha
KiTae Ha
BCByung Tae Choi
Byung Tae Choi
HSHwa-Kyoung Shin
Hwa-Kyoung Shin
Stroke is one of the major causes of death and long-term disability worldwide; the associated breakdown of the blood-brain barrier (BBB) aggravates ischemic brain damage. Accordingly, many medicinal herbs and formulas have been used to treat stroke-related symptoms. In this study, we selected two Korean herbal medicine formulas, Weisheng-tang and Tongxuewan, through Dongeuibogam text-mining analysis, and evaluated their protective effect on BBB disruption and brain damage in stroke. Ischemic brain damage was induced in mice by photothrombotic cortical ischemia. The infarct volume, brain edema, neurological deficits, and motor function 24 h after ischemic injury were analyzed. We investigated BBB breakdown by measuring Evans blue extravasation in addition to endothelial cells, tight junction proteins, protease-activated receptor-1 (PAR-1), and matrix metalloproteinase-9 (MMP-9) using immunofluorescence staining and confocal microscopy. Pretreatment with Weisheng-tang significantly reduced infarct volume and edema and improved neurological and motor functions; however, Tongxuewan did not. In addition, Weisheng-tang decreased brain infarction and edema and recovered neurological and motor deficit in a dose-dependent manner (30, 100, and 300 mg/kg). Weisheng-tang pretreatment resulted in significantly less BBB damage and higher brain microvasculature after focal cerebral ischemia. Tight junction proteins, such as zonula occludens-1 (ZO-1) and claudin-5, were preserved in Weisheng-tang-pretreated mice. Moreover, the ischemic brain in these mice showed suppressed PAR-1 and MMP-9 expression. In conclusion, our findings show that Weisheng-tang, which was selected through literature analysis but has not previously been used as a stroke remedy, exerts protective effects against ischemic brain damage and suggest its possible application for potential stroke patients, especially in the elderly.

21 January 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JLJae Ho Lee
Jae Ho Lee
Kyeong Hyeon LEEKyeong Hyeon LEE
Kyeong Hyeon LEE
JRJi Hyeon Ryu
Ji Hyeon Ryu
MKMin Jae Kim
Min Jae Kim
EKEunji Kim
Eunji Kim
HSHwa-Kyoung Shin
Hwa-Kyoung Shin
Stroke is globally recognized as the second leading cause of death, significantly impairing both motor and cognitive functions. Enhancing regeneration after stroke is crucial for restoring these functions and necessitates strategies to promote neuroregeneration to achieve better post-stroke outcomes. Brain-derived neurotrophic factor (BDNF) plays a key role in neuroregeneration by influencing motor ability, learning, memory, and rehabilitation after stroke. However, challenges such as the substantial protein size, short half-life of BDNF, and blood-brain barrier hinder its efficient delivery to the brain. In this study, LM22A-4, a BDNF mimetic, was utilized and delivered through a Smart Mesoporous Ball (SMB-3) system to target the ischemic injured brain and explore its potential therapeutic effects in a mouse ischemic stroke model. Treatment with LM22A-4-loaded SMB-3 (LM22A-4-SMB-3) markedly restored neurological, motor, and cognitive deficits following ischemic stroke compared to LM22A-4 alone. Additionally, administration of LM22A-4-SMB-3 reduced apoptotic cell death and glial activation, as evidenced by the TUNEL assay results, and decreased GFAP and Iba-1 expression levels. Furthermore, the phosphorylation of TrkB and Akt, but not that of Erk, was considerably increased in the LM22A-4-SMB-3-treated group. Treatment also enhanced the number of BrdU+/NeuN+ cells, with a marked reduction in post-stroke brain atrophy. These findings suggest that LM22A-4-SMB-3 can attenuate ischemic damage and recover neurological, motor, and cognitive functions by increasing p-TrkB and p-Akt levels and promoting neurogenesis. Therefore, SMB-3-mediated delivery of LM22A-4 presents a potentially applicable delivery system, and LM22A-4-SMB-3 use could be considered a novel therapeutic strategy to improve post-stroke outcomes.